Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
MicroRNA-21 with therapeutic potential in autoimmune diseases.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Natalizumab in the treatment of pediatric multiple sclerosis.
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
Longitudinal follow-up of vision in a neuromyelitis optica cohort.
Therapy optimization: a new model for managing high-cost biologics.
Current status of chemokines in the adult CNS.
A Qualitative Study Exploring the Usability of Nintendo Wii Fit among Persons with Multiple Sclerosis.
The clinical relevance of force platform measures in multiple sclerosis: a review.
Managing Disability in Progressive Multiple Sclerosis.
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.
IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
Transcriptional de-repression of ERVWE1 following influenza A virus infection.
Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients.
Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis.
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
Association between age at onset of multiple sclerosis and vitamin D level-related factors.
Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
Impaired decision-making and diffusion orientational complexity in people with multiple sclerosis.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.
Neuregulin and BDNF Induce a Switch to NMDA Receptor-Dependent Myelination by Oligodendrocytes.
Pages
« first
‹ previous
…
356
357
358
359
360
361
362
363
364
…
next ›
last »